Company Profile

AvantGen Inc
Profile last edited on: 12/31/2020      CAGE: 4NTY2      UEI: WLNHKNPNT2M7

Business Identifier: Proprietary yeast display system: fully human antibody (Germliner™) library and screening technologies
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

10151 Pacific Mesa Boulevard Suite 103
San Diego, CA 92121
   (858) 768-8107
Location: Single
Congr. District: 52
County: San Diego

Public Profile

AvantGen is a biotechnology company with therapeutic and bioscience divisions. The firm's proprietary and robust yeast display system, large human antibody database, multiple fully human antibody (Germliner™) libraries and screening technologies - AvantGen's Therapeutic Division (ATD) - are structured around novel human antibody discovery, antibody humanization, antibody affinity maturation and optimization, for therapeutic development as well as discovery of antibodies with novel formats for immunotherapy. AvantGen collaborates with pharmaceutical and biotechnology companies to facilitate and speed their path to antibody-based therapeutic development through services, partnerships, and licensing. Additionally, by combining AvantGen's yeast display system and the superior immune responses in rabbits, AvantGen has developed a novel platform to generate rabbit monoclonal antibodies with superior affinity and specificity. With this platform, AvantGen's Bioscience Division (ABD) is developing high quality rabbit monoclonal antibodies for high value diagnostic targets. The firm has developed novel antibodies against various targets for therapeutic, diagnostic development and successfully completed de novo antibody screening, antibody humanization and optimization projects for pharmaceutical and biotech companies, as well as academic institutions.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Xiaomin Fan -- President and Principal Scientist

  Jeffrey Billheimer

  Lakshmi A Devi

  Catherine M Woods

Company News

There are no news available.